Markets.com Logo
markets.com

PSBXP

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

PSBXP.US refers to the Invesco Balanced-Risk Allocation Fund, a mutual fund managed by Invesco. The fund seeks to provide long-term total return by allocating its assets across a variety of global asset classes, including equities, fixed income, commodities, and real estate. It aims to achieve a balanced risk profile through diversification and dynamic asset allocation, adjusting its exposures based on market conditions and risk assessments. The ".US" designation typically indicates that the fund is traded or offered within the United States.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Company Performance: Strong financial results, positive earnings reports, and successful product launches can drive the stock price up. Conversely, poor performance can lead to a decrease.

Market Sentiment: Overall investor mood and expectations regarding the market can influence the demand and supply of PSBXP.US shares, impacting its price.

Industry Trends: Developments and trends in the biotechnology industry, such as regulatory changes, technological advancements, or new drug approvals, can affect investor perception and the stock's value.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can impact investor confidence and spending, indirectly influencing stock prices.

News and Events: Company-specific news, such as clinical trial results, partnerships, or acquisitions, can cause significant price fluctuations.

Competitor Actions: Actions taken by competitors in the biopharmaceutical space, including the introduction of new drugs or the development of competing technologies, can affect PSBXP.US's market position and stock price.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com